Improvement in β-Cell secretory capacity after human islet transplantation according to the CIT07 protocol

Diabetes

Volumn 62, Issue 8, 2013, Pages 2890-2897

  Rickels, Michael R ^a   Liu, Chengyang ^b   Shlansky Goldberg, Richard D ^a   Soleimanpour, Scott A ^a   Vivek, Kumar ^b   Kamoun, Malek ^b   Min, Zaw ^b   Markmann, Eileen ^b   Palangian, Maral ^b   Dalton Bakes, Cornelia ^a   Fuller, Carissa ^a   Chiou, Allen J ^a   Barker, Clyde F ^b   Luning Prak, Eline T ^b   Naji, Ali ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BASILIXIMAB; C PEPTIDE; DACLIZUMAB; ENOXAPARIN; ETANERCEPT; GLUCOSE; HEPARIN; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTOXIFYLLINE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; ANTIDIABETIC AGENT; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; COLITIS; CONTROLLED STUDY; DETERIORATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; HEPARINIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN RESPONSE; INSULIN TREATMENT; INTERMETHOD COMPARISON; INTERSTITIAL PNEUMONIA; LOW DRUG DOSE; MALE; MIDDLE AGED; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; REPEATED DRUG DOSE; DIABETES MELLITUS, TYPE 1; PROCEDURES; SECRETION (PROCESS); TREATMENT OUTCOME; INSULIN DEPENDENT DIABETES MELLITUS; METHODOLOGY;

ADULT; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOSUPPRESSIVE AGENTS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MIDDLE AGED; SIROLIMUS; TACROLIMUS; TREATMENT OUTCOME;

EID: 84888332284     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-1802     Document Type: Article

References (47)

1. Barton FB, Rickels MR, Alejandro R, et al. Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care 2012;35:1436-1445
2. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230-238
3. Shapiro AMJ, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006;355:1318-1330
4. Rickels MR, Schutta MH, Markmann JF, Barker CF, Naji A, Teff KL. β-Cell function following human islet transplantation for type 1 diabetes. Diabetes 2005;54:100-106
5. Eriksson O, Eich T, Sundin A, et al. Positron emission tomography in clinical islet transplantation. Am J Transplant 2009;9:2816-2824
6. Greenbaum CJ, Prigeon RL, D'Alessio DA. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose. Diabetes 2002;51:951-957
7. Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005;293:830-835
8. Bellin MD, Kandaswamy R, Parkey J, et al. Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes [corrected in Am J Transplant 2010;10:1337]. Am J Transplant 2008;8:2463-2470
9. Bellin MD, Barton FB, Heitman A, et al. Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes. Am J Transplant 2012;12:1576-1583
10. CIT website [Internet], 2011. Available from http://www.isletstudy.org/. Accessed 1 May 2012
11. Rickels MR, Mueller R, Teff KL, Naji A. β-Cell secretory capacity and demand in recipients of islet, pancreas, and kidney transplants. J Clin Endocrinol Metab 2010;95:1238-1246
12. Rickels MR, Kearns J, Markmann E, et al. HLA sensitization in islet transplantation. In Clinical Transplants 2006. Cecka JM, Terasaki PI, Angles L, Eds. Los Angeles, CA, UCLA Tissue Typing Laboratory, 2007, p. 413-420
13. Ricordi C, Lacy PE, Scharp DW. Automated islet isolation from human pancreas. Diabetes 1989;38(Suppl. 1):140-142
14. Linetsky E, Bottino R, Lehmann R, Alejandro R, Inverardi L, Ricordi C. Improved human islet isolation using a new enzyme blend, liberase. Diabetes 1997;46:1120-1123
15. Markmann JF, Deng S, Huang X, et al. Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg 2003;237: 741-749; discussion 749-750
16. Bucher P, Mathe Z, Bosco D, et al. Serva collagenase NB1: A new enzyme preparation for human islet isolation. Transplant Proc 2004;36:1143-1144
17. Soleimanpour SA, Sekiguchi DR, LaRosa DF, Luning Prak ET, Naji A, Rickels MR. Hypersensitivity to rabbit antithymocyte globulin in an islet transplant recipient: A case report. Transplant Proc 2011;43:3302-3306
18. Ward WK, Halter JB, Beard JC, Porte D Jr. Adaptation of B and A cell function during prolonged glucose infusion in human subjects. Am J Physiol 1984;246:E405-E411
19. Larsson H, Ahrén B. Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine. Diabetologia 1998;41:772-777
20. Rickels MR, Naji A, Teff KL. Acute insulin responses to glucose and arginine as predictors of β-cell secretory capacity in human islet transplantation. Transplantation 2007;84:1357-1360
21. Digon BJ 3rd, Rother KI, Hirshberg B, Harlan DM. Sirolimus-induced interstitial pneumonitis in an islet transplant recipient (Letter). Diabetes Care 2003;26:3191
22. Rickels MR, Kamoun M, Kearns J, Markmann JF, Naji A. Evidence for allograft rejection in an islet transplant recipient and effect on β-cell secretory capacity. J Clin Endocrinol Metab 2007;92:2410-2414
23. Robertson RP. Estimation of beta-cell mass by metabolic tests: necessary, but how sufficient? Diabetes 2007;56:2420-2424
24. Kahn SE, Carr DB, Faulenbach MV, Utzschneider KM. An examination of beta-cell function measures and their potential use for estimating beta-cell mass. Diabetes Obes Metab 2008;10(Suppl. 4):63-76
25. Negi S, Park SH, Jetha A, Aikin R, Tremblay M, Paraskevas S. Evidence of endoplasmic reticulum stress mediating cell death in transplanted human islets. Cell Transplant 2012;21:889-900
26. Liu C, Koeberlein B, Feldman MD, et al. Accumulation of intrahepatic islet amyloid in a nonhuman primate transplant model. Endocrinology 2012; 153:1673-1683
27. Brennan DC, Schnitzler MA. Long-term results of rabbit antithymocyte globulin and basiliximab induction. N Engl J Med 2008;359:1736-1738
28. Eisenbarth GS, Srikanta S, Jackson R, et al. Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus. Diabetes Res 1985;2:271-276
29. Rabinovitch A, Sumoski W, Rajotte RV, Warnock GL. Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J Clin Endocrinol Metab 1990;71:152-156
30. Rizza RA, Mandarino LJ, Gerich JE. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab 1982;54:131-138
31. Farney AC, Xenos E, Sutherland DER, et al. Inhibition of pancreatic islet beta cell function by tumor necrosis factor is blocked by a soluble tumor necrosis factor receptor. Transplant Proc 1993;25:865-866
32. Strieter RM, Remick DG, Ward PA, et al. Cellular and molecular regulation of tumor necrosis factor-Alpha production by pentoxifylline. Biochem Biophys Res Commun 1988;155:1230-1236
33. Johansson H, Lukinius A, Moberg L, et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005;54: 1755-1762
34. Moberg L, Johansson H, Lukinius A, et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002;360:2039-2045
35. Koh A, Senior P, Salam A, et al. Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success. Transplantation 2010;89:465-471
36. Rickels MR. Recovery of endocrine function after islet and pancreas transplantation. Curr Diab Rep 2012;12:587-596
37. Davalli AM, Ricordi C, Socci C, et al. Abnormal sensitivity to glucose of human islets cultured in a high glucose medium: partial reversibility after an additional culture in a normal glucose medium. J Clin Endocrinol Metab 1991;72:202-208
38. Dubois S, Madec AM, Mesnier A, et al. Glucose inhibits angiogenesis of isolated human pancreatic islets. J Mol Endocrinol 2010;45:99-105
39. Ihm SH, Matsumoto I, Sawada T, et al. Effect of donor age on function of isolated human islets. Diabetes 2006;55:1361-1368
40. Niclauss N, Bosco D, Morel P, et al. Influence of donor age on islet isolation and transplantation outcome. Transplantation 2011;91:360-366
41. Bucher P, Mathe Z, Morel P, et al. Assessment of a novel two-component enzyme preparation for human islet isolation and transplantation. Transplantation 2005;79:91-97
42. Markmann JF, Tomaszewski J, Posselt AM, et al. The effect of islet cell culture in vitro at 24 degrees C on graft survival and MHC antigen expression. Transplantation 1990;49:272-277
43. Rickels MR, Naji A, Teff KL. Insulin sensitivity, glucose effectiveness, and free fatty acid dynamics after human islet transplantation for type 1 diabetes. J Clin Endocrinol Metab 2006;91:2138-2144
44. Hirsch D, Odorico J, Radke N, et al. Correction of insulin sensitivity and glucose disposal after pancreatic islet transplantation: preliminary results. Diabetes Obes Metab 2010;12:994-1003
45. Meier JJ, Hong-McAtee I, Galasso R, et al. Intrahepatic transplanted islets in humans secrete insulin in a coordinate pulsatile manner directly into the liver. Diabetes 2006;55:2324-2332
46. Kneteman NM, Lakey JR, Wagner T, Finegood D. The metabolic impact of rapamycin (sirolimus) in chronic canine islet graft recipients. Transplantation 1996;61:1206-1210
47. Naziruddin B, Wease S, Stablein D, et al. HLA class 1 sensitization in islet transplant recipients: report from the Collaborative Islet Transplant Registry. Cell Transplant 2012;21:901-908